Pixantrone

Generic Name
Pixantrone
Brand Names
Pixuvri
Drug Type
Small Molecule
Chemical Formula
C17H19N5O2
CAS Number
144510-96-3
Unique Ingredient Identifier
F5SXN2KNMR
Background

Pixantrone is an aza-anthracenedione and DNA intercalator which inhibits topoisomerase II. It is similar in structure to anthracyclines such as mitoxantrone, but exerts fewer toxic effects on cardiac tissue. [2] The lower cardio-toxic effects of pixantrone may be explained, in part, by its redox inactivity [3]. Pixantrone does not bind iron and promotes the ...

Indication

Currently in Phase III investigation for treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma in patients who have failed two prior lines of therapy. Presently, no standard therapy exists for patients with relapsed or refractory NHL. [2] After first line therapy has been initiated, most patients have received their lifetime limit of doxorubi...

Associated Conditions
Non-Hodgkin's Lymphoma, Relapsed, Refractory Non-Hodgkin's lymphoma
Associated Therapies
-

Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

First Posted Date
2018-03-08
Last Posted Date
2024-10-09
Lead Sponsor
The Lymphoma Academic Research Organisation
Target Recruit Count
74
Registration Number
NCT03458260
Locations
🇧🇪

Centre Hospitalier de Jolimont, Haine-Saint-Paul, Belgium

🇫🇷

Clinique Victor Hugo, Le Mans, France

🇧🇪

AZ Sint Jan, Brugge, Belgium

and more 19 locations

Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer

Phase 1
Withdrawn
Conditions
Interventions
First Posted Date
2016-06-15
Last Posted Date
2020-01-29
Lead Sponsor
CTI BioPharma
Registration Number
NCT02800889
Locations
🇺🇸

Children's Hospital Los Angeles, Los Angeles, California, United States

Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic Impairment

Phase 1
Withdrawn
Conditions
Interventions
First Posted Date
2012-07-03
Last Posted Date
2023-10-02
Lead Sponsor
CTI BioPharma
Registration Number
NCT01632436
Locations
🇺🇸

UTHSCSA-Cancer Therapy-Research Center, San Antonio, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath